摘要
该文归纳了脑梗死形成的6条危险因素,总结了脑梗死现阶段溶栓、改善微循环、抗凝、降低颅内压、神经细胞保护、基因、中医、血液平衡及骨髓间质干细胞等治疗进展情况。脑梗死是基因治疗的潜在目标。碱性成纤维细胞生长因子(bFGF)对缺血性脑损伤有神经保护作用;凋亡抑制基因(bcl-2)转基因技术可使脑梗死体积缩小。中医治疗脑梗死效果明显。川芎嗪能改善急性脑循环障碍,使异常的血流状态转为正常的血流状态;灯盏细辛注射液具有舒张脑血管、增加脑血流、改善微循环、清除自由基等作用。骨髓间质干细胞治疗脑梗死研究已取得进展,未来骨髓间质干细胞在治疗脑梗死中会发挥重要作用。
This paper summarizes the 6 risk factors of the formation of cerebral infarction,and concludes the present treatments of cerebral infarction,including thrombolysis,improving microcirculation,anticoagulation,reducing intracranial pressure,nerve cell protection,gene therapy,traditional Chinese medicine treatments,balance of blood means,the method of bone marrow mesenchymal stem cells and other treatment progress.Cerebral infarction is potential target of gene therapy.bFGF has neuroprotective effect on ischemic brain injury.Transgenic technology of bcl-2 can reduce the volume of cerebral infarction.Traditional Chinese medicine has significant effect in curing of cerebral infarction.TMP can improve cerebral circulation of acute cerebral circulation obstacle,and can transform abnormal blood flow to normal.Erigeron Injection can diastolic cerebral blood vessels,increase cerebral blood flow,improve microcirculation,eliminate free radical and so on.Bone marrow mesenchymal stem cells research has made great progress in treatment of cerebral infarction.It may play an important role in this area in the future.
出处
《职业与健康》
CAS
2011年第6期686-688,共3页
Occupation and Health
关键词
脑梗死
危险因素
治疗
Cerebral infarction
Risk factors
Treatment
